Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer.

Akolkar D, Patil D, Crook T, Limaye S, Page R, Datta V, Patil R, Sims C, Ranade A, Fulmali P, Fulmali P, Srivastava N, Devhare P, Apurwa S, Patel S, Patil S, Adhav A, Pawar S, Ainwale A, Chougule R, Apastamb M, Srinivasan A, Datar R.

Int J Cancer. 2019 Nov 30. doi: 10.1002/ijc.32815. [Epub ahead of print]

PMID:
31785151
2.

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial.

Nagarkar R, Patil D, Crook T, Datta V, Bhalerao S, Dhande S, Palwe V, Roy S, Pandit P, Ghaisas A, Page R, Kathuria H, Srinivasan A, Akolkar D.

Oncotarget. 2019 Sep 24;10(54):5605-5621. doi: 10.18632/oncotarget.27188. eCollection 2019 Sep 24.

3.

Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC.

Ranade A, Patil D, Bhatt A, Dhasare R, Datta V, Datar R, Akolkar D.

J Pers Med. 2019 Jul 5;9(3). pii: E34. doi: 10.3390/jpm9030034.

Supplemental Content

Loading ...
Support Center